Skip to main content
Equibles

MetLife Investment Management, LLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1529735 Whippany, NJ
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$324,844
+$144,975 QoQ
Shares Held
156,175
+111.9% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 209 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. ALLO ranks #156 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in ALLO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $324,844 156,175
2026-03-31 $179,869 73,717
2025-12-31 $47,707 34,823
2025-09-30 $70,998 57,257
2025-03-31 $116,541 79,823
2024-12-31 $80,982 38,020
2024-09-30 $148,811 53,147
2024-06-30 $137,796 59,140
2024-03-31 $219,030 49,000
2023-12-31 $134,877 42,018
2023-09-30 $133,197 42,018
2023-06-30 $208,829 42,018
2023-03-31 $207,568 42,018
2022-12-31 $264,293 42,018
2022-09-30 $453,794 42,018
2022-06-30 $459,990 40,350
2022-03-31 $330,929 36,326
2021-12-31 $341,772 22,907
2021-09-30 $588,709 22,907
2021-06-30 $597,414 22,907
2021-03-31 $808,617 22,907
2020-12-31 $578,172 22,907
2020-09-30 $863,822 22,907
2020-06-30 $923,027 21,556
2020-03-31 $350,094 18,009